Certara, Inc. (CERT) NASDAQ

5.62

-0.5(-8.17%)

Updated at June 02 04:00PM

Currency In USD

Key Executives

Name	Title	Pay	Year Born
Jon Resnick	Chief Executive Officer & Director	1.4M	1973
Leif E. Pedersen	President & Chief Commercial Officer	690,082	1965
Robert Aspbury	President of Certara Predictive Technologies	826,125	1972
John E. Gallagher	SVP, Principal Accounting Officer & Chief Financial Officer	924,248	1973
Adrian K. McKemey	President of Drug Development Solutions	1.08M	N/A
Ron DiSantis	Senior Vice President of Corporate Development	0	N/A
Rona Anhalt	Chief Human Resources Officer	0	1965
Sheila Rocchio	Chief Marketing Officer	0	N/A
Daniel Corcoran	Senior Vice President, General Counsel & Secretary	0	1967
Christopher Bouton	Chief Technology Officer & Chief AI Officer	0	N/A
Martin Snyder	President of Certara Data Sciences	0	N/A
Frederic Yves Bois	Senior Scientific Advisor, Head of Mechanistic Modeling & Member of Simcyp Advisory Board	0	N/A

Name

Title

Pay

Year Born

Jon Resnick

Chief Executive Officer & Director

1.4M

1973

Leif E. Pedersen

President & Chief Commercial Officer

690,082

1965

Robert Aspbury

President of Certara Predictive Technologies

826,125

1972

John E. Gallagher

SVP, Principal Accounting Officer & Chief Financial Officer

924,248

1973

Adrian K. McKemey

President of Drug Development Solutions

1.08M

N/A

Ron DiSantis

Senior Vice President of Corporate Development

N/A

Rona Anhalt

Chief Human Resources Officer

1965

Sheila Rocchio

Chief Marketing Officer

N/A

Daniel Corcoran

Senior Vice President, General Counsel & Secretary

1967

Christopher Bouton

Chief Technology Officer & Chief AI Officer

N/A

Martin Snyder

President of Certara Data Sciences

N/A

Frederic Yves Bois

Senior Scientific Advisor, Head of Mechanistic Modeling & Member of Simcyp Advisory Board

N/A

Description

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.